OPTHEA LIMITED

CKDXF ·Healthcare, Drug Manufacturers - General
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $25.0K $125.0K $108.0K $90.7K $68.6K $59.1K $112.5K
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense
Operating Income $-155.8M $-191.8M $-150.0M $-96.5M $-50.3M $-16.8M $-25.4M
Operating Margin -623,048.0% -153,473.6% -138,912.0% -106,456.7% -73,285.4% -28,499.3% -22,601.8%
Interest Expense $46.5M $30.3M $13.5M $0
Pretax Income $-169.7M $-229.7M $-148.4M $-99.1M $-50.3M $-16.8M $-25.4M
Income Tax Expense $-6.9M $-9.4M $-5.9M $-6.3M $-4.9M $-5.7M $-10.5M
Net Income $-162.8M $-220.2M $-142.5M $-92.8M $-45.3M $-11.1M $-15.0M
Net Margin -651,164.0% -176,193.6% -131,963.9% -102,353.7% -66,087.3% -18,833.4% -13,291.0%
EPS (Basic) $-0.13 $-0.35 $-0.32 $-0.26 $-0.14
EPS (Diluted) $-0.13 $-0.35 $-0.32 $-0.26 $-0.14
Shares Outstanding (Basic)
Shares Outstanding (Diluted)
Dividends Per Share